Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
about
A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphismSmoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohortCytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease studyPlatelet aggregation and incident ischaemic heart disease in the Caerphilly cohortElevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genesAspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variablesFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewTumor necrosis factor receptor levels are associated with carotid atherosclerosisHomocysteine and ischaemic stroke in men: the Caerphilly studyHomocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow upLung injury after cigarette smoking is particle relatedConcentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteersSonic Estimation of Elasticity via Resonance: A New Method of Assessing Hemostasis.Thickness dependent effective viscosity of a polymer solution near an interface probed by a quartz crystal microbalance with dissipation method.The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study.Effort-reward imbalance at work and incident coronary heart disease: a multi-cohort study of 90,164 individuals.Health status as a potential effect modifier of the relation between noise annoyance and incidence of ischaemic heart disease.Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations.The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments.Recent advances in ischaemic heart disease.The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.Blood pressure reactions to the cold pressor test and the prediction of ischaemic heart disease: data from the Caerphilly Study.Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study.Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's diseaseEffects of work place carbon monoxide exposure on blood viscosity.Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health StudyDoes weight loss reduce plasma fibrinogen?Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective studyIschaemic heart disease: association with haematocrit in the British Regional Heart Study.Air pollution and mortality in Barcelona.Expanded network of inflammatory markers of atherogenesis: where are we now?Occupational exposure to dust: inflammation and ischaemic heart diseaseFactor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.Diet and hemostatic factors.Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.The biology behind the atherothrombotic effects of cigarette smoke.Traffic noise and cardiovascular risk: the Caerphilly and Speedwell studies, second phase. Risk estimation, prevalence, and incidence of ischemic heart disease.The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease.Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran.
P2860
Q24297061-A429CCC8-114D-4BB0-9214-A085D739E490Q24672992-B02CF3D7-6FCA-4BB5-B2A1-20571F2B681BQ24683839-CEAB97C4-975C-4620-907F-27C8CEE3612AQ24683880-D2EE806D-39B5-4A02-B115-2DB390C032C6Q24793954-8853B4D3-03E9-422D-8F12-E505317BE20CQ28200267-2C2175EA-A889-47CF-8E28-37003779A1C1Q28220294-29E18D44-EDD0-4B6F-9C6F-6EE9FBFF4CB2Q28344629-910ABB82-A15F-43FA-8E6C-04C43A757F8AQ28345707-D194B350-AE14-40EC-BDD2-AF556F5E3536Q28345971-E7B252B4-D98D-4ED7-A321-C5702F143029Q28389025-3CB275E4-1A29-4FF6-9BBA-E62D21910D2CQ29618549-C69370C3-7470-4F0B-A56D-F92E387F7EE6Q30357463-CE9B6480-2C8C-4A19-839E-AF4B1A40A0FDQ30418241-2862CAB6-09AA-4B39-AA32-15E4B4067037Q30467949-CDF94EC8-8755-4FC8-8342-75D5B7DFEC1DQ30491269-655926E4-A3F7-4D3D-B4A4-A5E7BE71E288Q30496316-3972CB8D-3536-46E1-828D-205BCB4FC53FQ30634073-8A3ACA71-5693-44D6-B4B3-368182A6F943Q30892742-EFE3189E-E8B1-44CD-802E-4A27E40581F8Q30912640-8510EFDE-3232-40CD-BCCC-8437C9AC9DEFQ31129827-BF4E9433-209A-4A9D-AED1-5345B4F28DF0Q31941389-C6B89922-1EA4-4BB7-8F6B-D7EC0D97BC75Q33168801-8F8AA4AA-BF00-4FEC-A94E-475369D54D1DQ33287487-D4C4E9C7-83B7-4426-B8CE-47F33BF35647Q33530580-6B4FEB89-8920-42CE-A107-D39F60D32F73Q33612628-0F92E7D1-39F2-4738-AAF6-7F04F736A431Q33613250-03B99EEB-44B2-4905-A36E-50E536692AA3Q33613645-5D18AB72-25C8-460A-B05A-A7ED008BADDDQ33702283-29E2E699-AF2A-467B-9135-BBCC901AC403Q33705858-507B1B8D-4BE9-4856-892A-95690F885BF1Q33738532-ECF78937-DD6B-4C8A-BD58-3864A67692DAQ33820733-2D1FCCE1-8162-45D0-81F1-F2632D72668FQ33861058-93B07650-BE14-4FCF-B627-CECD561342DAQ33911689-43C752EF-2687-4D7D-BAAE-0D2841A58DE8Q34107288-38F56889-9C33-4C05-A1A7-466143FBA9BDQ34140740-0876BB41-01A5-4F5D-830A-1B6F0D6D9034Q34326163-070E0364-D325-4E14-8CE5-3619B0BA6749Q34345582-7E6987C8-8AC2-4E19-847D-8E39E741765FQ34557697-6C403506-0945-4B5E-9022-6DFE0BADC6BAQ34609163-9F8213DE-7441-49E2-9C52-123EE652CE89
P2860
Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@en
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@nl
type
label
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@en
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@nl
prefLabel
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@en
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@nl
P2093
P356
P1433
P1476
Fibrinogen, viscosity, and whi ...... orative heart disease studies.
@en
P2093
O'Brien JR
Sweetnam PM
Whitehead PJ
Yarnell JW
P304
P356
10.1161/01.CIR.83.3.836
P407
P577
1991-03-01T00:00:00Z